|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| CURRENT ASSETS: | |||||||
| Cash and cash equivalents | |||||||
| Restricted cash | |||||||
| Short-term deposits | |||||||
| Trade receivables, net | |||||||
| Inventory | |||||||
| Other current financial assets | |||||||
| Other current assets | |||||||
| Total current assets | |||||||
| NON-CURRENT ASSETS: | |||||||
| System components | |||||||
| Leased systems, net | |||||||
| Other property and equipment, net | |||||||
| Right-of-use assets | |||||||
| Other long-term assets | |||||||
| Other non-current financial assets | |||||||
| Total non-current assets | |||||||
| Total assets | |||||||
| LIABILITIES AND EQUITY | |||||||
| CURRENT LIABILITIES: | |||||||
| Trade payables | |||||||
| Deferred revenues | |||||||
| Liability in respect of research and development grants | |||||||
| Liability in respect of government grants | |||||||
| Current maturities of lease liabilities | |||||||
| Other accounts payable | |||||||
| Total current liabilities | |||||||
| NON-CURRENT LIABILITIES: | |||||||
| Deferred revenues and other liabilities | |||||||
| Liability in respect of research and development grants | |||||||
| Deferred revenues | |||||||
| Liability in respect of government grants | |||||||
| Lease liabilities | |||||||
| Warrants liability | |||||||
| Total non-current liabilities | |||||||
| EQUITY: | |||||||
| Share capital Ordinary shares of NIS 0.04 par value: Authorized- 120,000,000 ordinary shares; Issued and outstanding- 39,165,805 ordinary shares on December 31, 2025 and 37,626,427 ordinary shares on December 31, 2024 | |||||||
| Share premium | |||||||
| Reserve for share-based payment | |||||||
| Currency translation adjustments | |||||||
| Accumulated deficit | |||||||
| Total equity | |||||||
| Total equity and liabilities | |||||||
Loading...